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Summary 
A number of investigations have established the critical role ofinterleukin 4 (IL-4) in mediating 
the development of T  helper (Th)2 effector cells in vitro and in vivo. Despite intensive study, 
the origin of the IL-4 required for Th2 priming and differentiation remains unclear. Natural 
killer (NK)1.1 + ot/[3 T cell receptor  + T  (NT) cells, a unique lineage of cells capable of produc- 
ing large amounts of IL-4 after activation in vivo, are important candidates for directing Th2 
priming.  These cells  are selected by the  nonpolymorphic major histocompatibility complex 
(MHC)  class I molecule, CD1,  and are deficient in [~2-microglobulin ([32m)-null mice. We 
used [32m-deficient mice on both BALB/c and C57BL/6 backgrounds to examine their capacity 
to mount Th2 immune responses after challenge with a number of well-characterized antigens 
administered by a variety of routes. As assessed by immunization with protein antigen, infec- 
tion with Leishmania  major,  embolization with eggs of Schistosoma  mansoni,  intestinal infection 
with Nippostrongylus  brasiliensis,  or induction of airway hyperreactivity to aerosolized antigen, 
[32m-deficient mice developed functional type 2 immune responses that were not substantially 
different than those in wild-type mice. Production of IL-4 and the generation ofimmunoglob- 
ulin E  (IgE)  and eosinophil responses were preserved as assessed by a variety of assays. Collec- 
tively, these results present a comprehensive analysis of type 2 immune responses in [32m-defi- 
cient mice, and indicate that [32m-dependent NT cells are not required for Th2 development 
in vivo. 
D 
ifferentiation of CD4 + T  cell subsets  can be modu.- 
lated by a number of variables, including route of an~- 
tigen administration  (1),  antigen dose  (2,  3),  activation of 
distinct costimulatory pathways  (4),  interactions with dis- 
tinct populations of APC (5), use of altered ligands  (6), un~- 
derlying genetic propensities (7), and changes in the cyto~ 
kine milieu during the period of T  cell priming (8-11). Ol  a 
these, the latter is particularly dominant, as demonstrated by 
the profound effects on T helper cell (Th) 1 developmentin 
vitro or in vivo by exogenous cytokines or anticytokine anti- 
bodies and in mice with disruption of distinct cytokine genes. 
Of major importance are the cytokines IL-12 and IFN-~/ 
for Thl development and IL-4 for Th2 development. The 
critical role for IL-12 and IFN-~/in Thl differentiation has 
1Abbreviations  used  in  this paper: Ach, acetylcholine chloride; ~2m, 
132-microglobulin; HPP..T, hypoxanthine-guanine  phosphoribosyltrans- 
ferase; NT, natural T cells; 1<  t, lung resistance; Th, T helper  cell. 
been suggested by studies with neutralizing antibodies (12- 
14) and in mice with disruption of the IL-12 p40  (15)  or 
IFN-y (16) genes in which Thl responses are substantially 
abrogated in response to pathogens that otherwise induce 
type  1 immune  responses by the  host.  Macrophages,  and 
perhaps dendritic cells, are generally regarded to be the pri- 
mary sources of IL-12 in vitro and in vivo (17),  whereas 
NK cells  may be the  predominant source of IFN-~/  pro- 
duced early in the  immune  response (18).  These findings 
have supported a model whereby cells  of the  innate  im- 
mune system generate these cytokines upon their interac- 
tion with  various  pathogens,  thus  directing the  develop- 
ment  of Thl  responses by ceils  of the  adaptive  immune 
system (19). 
A critical role for IL-4 in Th2 development has also been 
demonstrated through use of exogenous IL-4 or neutraliz- 
ing antibodies (8-10), and in mice with gene disruption of 
IL-4  (20)  or  the  IL-4R.-dependent  transcription  factor, 
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ute the IL-4 required during antigen priming for the devel- 
opment of Th2 cells have not been identified. Studies using 
passive transfer of CD4 + T  cells into mice with disruption 
of the  IL-4 gene  suggested that CD4 +  T  ceils alone were 
sufficient for the generation of lgE production upon subse- 
quent antigen challenge (23). Thus, although mast cells and 
basophils  (24,  25),  and  perhaps  eosinophils  (26),  can pro- 
duce  IL-4, these  cell types did not seem to be required in 
vivo. 
An  unusual  CD4 +  T  cell that  expresses  the  phenotype 
CD4 +  NKI.1 +  c~/13 TCIL +  was  recently shown  to  pro- 
duce  essentially all  of the  IL-4  generated  over  the  initial 
30-120  min  in  response  to  intravenous  injection  of anti- 
CD3 mAb in vivo (27).  This population is distinguished by 
expression of a  skewed  TCR  repertoire,  characterized by 
an invariant TCIL e~ chain, Vod4Jot281,  together with a  [3 
chain biased toward use of V]38, V137, or V]32 (28). In con- 
trast  to  conventional  CD4 +  0~/]3 TCP, +  cells that  are  se- 
lected by  MHC  class  II/peptide complexes  expressed  on 
thymic  epithelial cells, NKI.1 +  T  cells or natural T  (NT) 
cells are selected by the  nonpolymorphic  class I  molecule, 
CD1,  expressed  on  immature  CD4+CD8 +  thymocytes 
(29,  30).  Disruption  of the  ]32-microglobulin (]32m)  gene 
impairs surface expression of CD1  (31, 32) and NT cells are 
physically and  functionally  absent  from  such  mice  as  as- 
sessed by flow cytometric analysis and by the lack of IL-4 
production  after  injection  of anti-CD3  in  vivo  (32,  33). 
The absence of IgE production by such mice after injection 
of anti-lgD,  a  powerful stimulus  for Th2  development in 
vivo, suggested the  hypothesis that NT  cells might repre- 
sent a critical cell population required as a source oflL-4 in 
directing the differentiation of Th2  cells (33).  To  evaluate 
the role of NT cells in Th2  differentiation in vivo, we used 
~2m-deficient mice to assess CD4 + subset development in 
a  variety of well-characterized Th2  challenges,  which  in- 
cluded responses to soluble subcutaneous antigen, intestinal 
helminth  infection,  induction  of airway  hyperreactivity, 
eggs of Schistosoma  mansoni,  and the intracellular protozoan, 
Leishmania  major. 
Materials and Methods 
Mice.  Female 6-8-wk-old C57BL/6, BALB/c, and 132m -/- 
mice backcrossed 10  generations to  C57BL/6  or BALB/c were 
obtained from The Jackson Laboratory (Bar Harbor, ME). 
Immunization  with KLH.  KLH  (Calbiochem-Novabiochem, 
La Jolla, CA) was dispersed into a 1:1 emulsion of PBS with CFA 
(Sigma  Chemical  Co.,  St.  Louis, MO).  Mice were  immunized 
with 50  ILl (75  Ixg KLH) in each hind footpad. Popliteal lymph 
nodes were removed after 7-11  d, disrupted into single cell sus- 
pensions, and duplicate aliquots of 106 cells were cultured in 200 I*1 
complete Iscove's media (10% FCS, 2 nLM L-glutamine,  100 U/ml 
penicillin, 100 b~g/ml  streptomycin, 5.5  ￿  t0  s M  2-mercapto- 
ethanol) in microtiter wells of 96-well round-bottomed plates in 
the presence or absence of 100  I~g/ml KLH.  Superllatants were 
collected after 48 h for cytokine ELISA (below). 
L.  majorinfectio~.  L.  major (WHOM/IlL/-/173)  was  pas- 
saged serially in  BALB/c  mice  to  maintain  virulence.  Parasites 
were  harvested  from  infected  animals  and  cultured  in  vitro  at 
26~  in M-199 medium (plus 20% FCS, 2 mM L-glutamine, 100 
U/ml penicillin, 100 Izg/ml streptomycin) for no longer than 2 mo 
before experimental infection. Late stationary-phase cultures were 
enriched for metacyclic promastigotes by incubation with peanut 
agglutinin-conjugated agarose beads (Sigma Chemical Co.) as de- 
scribed (34). Mice were inoculated with 5 ￿  105 metacyclic pro- 
mastigotes in each hind footpad and disease progression was mon- 
itored weekly by measuring the footpads with  a  metric caliper. 
Designated mice received 5  mg of mAb  lIB11  (rat  IgG1  anti- 
murine IL-4) intraperitoneally  at the time of infection. After 6-8 wk, 
the popliteal lymph nodes draining the lesion were collected for 
cytokine determinations, the footpads and spleens were harvested 
for parasite burdens, and serum was  collected for quantitation of 
total lgE. 
For the quantitation of parasites,  footpads were washed in eth- 
anol, rinsed in HBSS, and homogenized in 3 ml M-199 medium. 
Spleens were  homogenized  in  3  ml  M-199  medium.  Aliquots 
were  serially diluted in  flat-bottomed 96-well microtiter plates. 
Plates were sealed with parafilm and incubated at 26~  for 1 wk. 
Motile promastigotes were detected using inverted microscopy. 
S. mansoni Egg-induced Pulmonary Granuloma.  Eggs of S. mans0ni 
were extracted from livers of infected mice (Biomedical Research 
Institute,  tLockville, MD)  and  enriched for mature  eggs  as  de- 
scribed (35). Mice were presensitized by intraperitoneal injection 
of 5,000 eggs. 4 wk later, mice were challenged with intravenous 
injection of 5,000 eggs to induce synchronous granuloma forma- 
tion after entrapment in the lungs. Animals were killed tbr analy- 
sis 6 or 10 d after egg injection during the peak period of the im- 
mune granulomatous response (36). 
For quantitation ofgranuloma formation, the 1eft lung was in- 
flated with Bouin-Hollar~de fixative before processing. The size 
of the granulomas was determined microscopically from  4-1~m- 
thick sections stained using Litt's modification of the  Dominici 
stain (37). The diameters of each granuloma that contained a sin- 
gle egg were measured using an ocular micrometer and the vol- 
umes  of  the  granuloma  were  calculated  assuming  a  spherical 
shape. The numbers of eosinophils were numerically evaluated in 
the same sections. 
Induction qf Airway H},perreactivity.  Airway  hyperreactivity  was 
induced  and  quantitated  as  described  (38).  Briefly,  groups  of 
BALB/c or [32m -/-  BALB/c  imce were immunized subcuta- 
neously with 25 I~g turkey OVA (Sigma Chemical Co.) and alum 
weekly for 4  wk and subsequently exposed to  three aerosoliza- 
tions of 50 mg/ml OVA in PBS nebulized by compressed air and 
administered through  a  nose-only chamber over 20  rain at 2-d 
intervals.  1 d  after the final aerosol, mice were anesthetized and 
maintained inside a plethysmograph on rodent ventilators (Har- 
vard Apparatus Co., Inc., S. Natick, MA) on 100% oxygen under 
conditions  such  that  physiologic arterial  blood  gas  parameters 
other than elevated Pao2 were maintained.  Lung resistance (RL) 
was  determined by continuously quantitating the quotient APt/ 
AV (where APt =  change in tracheal pressure and AV =  change 
in flow) at 70%  tidal volume. After establishing a stable baseline 
for RL (<5% variation over 3 rain), acetylcholine chloride (Ach; 
Sigma Chemical Co.) was administered intravenously over 1 s in 
increasing doses.  The provocative concentration of Ach (micro- 
grams per gram) that caused a 200% increase in tZ  L was calculated 
from linear interpolation of appropriate dose-response curves as 
described (39). 
Immediately  after  collection  of the  physiologic  parameters, 
mice  were  killed and  single-cell suspensions of lung  cells  pre- 
pared.  Briefly,  the  lungs  were  completely blanched  with  cold 
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into PBS using a syringe plunger and passage over a 0.75-1~m ny- 
lon mesh filter.  Cells were washed  twice, counted, and adjusted 
to  107 cells/ml in RPMI  1640 with 5% fetal bovine serum and 
antibiotics for cytokine ELISPOT assays (below)  and enumera- 
tion of eosinophils  using phloxine B staining (Unopette; Becton 
Dickinson and Co., San Jose,  CA). Serum was prepared for the 
determination of total IgE by ELISA (below). 
Nippostrongylus brasiliensis Infection.,  Infective N. brasiliensis third- 
stage  larvae  were  isolated  from the  feces of experimentally in- 
fected" rats after 7 d of charcoal and peat moss/fecal  culture by di- 
rect pipetting after migration into the liquid PBS media.  Worms 
were washed repeatedly  in saline, counted, and injected into des- 
ignated groups of C57BL/6 or ~2m -/-  C57BL/6 mice subcu- 
taneously at the base of the tail using 500 organisms/mouse in 0.2 ml 
PBS. Mice were killed after 12 d and the numbers of adult worms 
were determined by direct visualization  after opening the intes- 
tines with an enterotome. Immunocompetent  mice expulse adult 
worms in a CD4-dependent manner after  10 d  (40). Single-cell 
suspensions of lung cells were prepared as described above (Induc- 
tion of Airway  Hyperreactivity) for cytokine ELISPOT assays, and 
blood was collected for determination of eosinophil numbers and 
total serum IgE levels. 
Cytokine mRNA Analysis.  For  the  leishmania  experiments, 
popliteal lymph node cell suspensions were used for extraction of 
total RNA using RNAzol (Biotecx,  Houston, TX).  RNA was 
reverse  transcribed using random hexamer primers  according to 
the manufacturer's specifications  (Promega  Corp., Madison, WI) 
and used in a competitive PCR analysis as previously described 
(41).  Briefly,  a  multiple cytokine-containing competitor  con- 
struct was used to equalize the amounts of input cDNA from the 
different  samples by adjusting for competition with the constitu- 
tively expressed hypoxanthine-guanine  phosphoribosyltransferase 
(HPRT) product. These adjusted volumes of cDNAs were then 
used  in subsequent reactions  with primers  for specific cytokines 
that were  also engineered as larger  competitive products in the 
PCR competitor by insertion of an internal irrelevant DNA se- 
quence. Because of their slower mobility in 2.5% agarose gels, the 
competitor products can be readily separated  from the authentic 
transcripts on the basis of size. The ratio of the competitor to the 
authentic cytokine transcripts was used to quantitate mRNA pro- 
duction in vivo. 
For the  schistosoma  experiments, one lobe of the  right lung 
was  homogenized using a  tissue polytron (Omni International, 
Waterbury, CT) in 1 ml RNA STAT-60 (Tel-Test,  Inc., Friends- 
wood, TX) and the total RNA isolated according to the manu- 
facturer's  specifications.  Cytokines were  quantitated using a re- 
verse  transcription-PCR-based method using primers for  IL-4, 
IL-5, IL-13, and HPRT as an internal control as previously de- 
scribed  (36). The amplified  cDNAs were analyzed after electro- 
phoresis  in agarose and Southern blotting with cytokine-specific 
probes.  The chelniluminescent signals were quantitated using a 
600 ZS scanner (600 ZS; Microtek International, Torrance, CA) 
and the amount of product determined by comparison of the sig- 
nal intensity with a standard curve generated from simultaneously 
amplified  stepwise  dilutions of cDNA containing large amounts 
of the specific cytokine mRNAs. Fold increase was calculated as 
the reciprocal  of the equivalent dilution of control (noninjected 
mouse lung) cDNA. 
Cytokine ELISA.  Antigen-specific cytokine production was 
determined by culturing 10  ~ draining lymph node cells per well 
in a 96-well round-bottomed plate at 37~  and 5% CO2 in com- 
plete Iscove's media. Designated wells from L. major experiments 
received 100 Dg/ml soluble Leishmania antigens,  or antigen plus 
mAb M5/114 (anti-IA  b'd and -IE  d,k, rat IgG2b).  After 48 h, IL-4 
and IFN-"/levels in the supematants were determined by ELISA 
(PharMingen, San Diego, CA). 
Cytokine ELISPOT.  For the airway byperreactivity and Nip- 
postrongylus experiments, single-cell suspensions of lung cells were 
distributed in duplicate  aliquots  of 10  (' cells in RPMI 1640 with 
5% FCS and antibiotics to 96-well microtiter plates (Immunolon 
IV; Dynatech, Chantilly, VA) that had been precoated with ei- 
ther mAb 11bll  (anti-murine IL-4, rat  IgG1)  or mAb R46A2 
(anti-murine IFN-',/, rat  IgG1).  Serial threefold dilutions of the 
cells were performed and the plates were incubated undisturbed 
for 8 h  at 37~  After washing away the cells, biotinylated sec- 
ondary antibodies against IL-4 (BVD6-24G.2, rat IgG1) or IFN-y 
(XMG-1.2,  rat  IgG1)  were  added,  and,  after  1 h,  wells  were 
washed and incubated with 100 b~l streptavidin-conjugated alka- 
line phosphatase  (Jackson ImmunoResearch Laboratories,  Inc., 
West Grove, PA) for 1 h.  Color was developed with 5-bromo- 
4-chloro-indolyl- phosphate  in 0.1  M 2-amino-2-methyl-l-pro- 
panol buffer (Sigma Chemical Co.)  suspended in 0.6%  agarose 
(Sea-Plaque;  FMC Bioproducts Inc., Rockland, ME).  After  so- 
lidification of the agar, individual  blue spots were counted by in- 
verted microscopy. 
Quantitation of Serum IgE.  Serum  from  designated animals was 
collected at the time of death  and total IgE was qnantitated by a 
sandwich ELISA using commercial mAb pairs (PharMingen) ac- 
cording to the manufacturer's instructions. 
Results 
Evaluation  of Th2  Responses  to a  Subcutaneously  Adminis- 
tered Protein Antigen.  Subcutaneous administration of KLH 
with  adjuvant  establishes  substantial  IL-4  production  by 
lymph node cells draining the site of immunization  that can 
be  demonstrated by  restimulation of the  isolated  T  cells 
with KLH in vitro (42). To assess the contribution by NT 
cells in priming for  IL-4  production,  groups  of BALB/c 
[~2m  +/-  or 132m -/-  littermates were immunized with 
KLH and the lymph node cells isolated and restimulated in 
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Figure  1.  Production  of IL-4 after immunization with KLH. Four 
BALB/c heterozygous (~82m +) or deficient (~2m -/-)  littermates  were 
immunized subcutaneously  with KLH in CFA and the draining lymph 
node cells collected after 11  d and incubated in vitro with 100 Dg/ml 
KLH. After 48 h, supernatants were collected and assayed for IL-4 by 
ELISA. Cells  incubated in the absence  of KLH produced <25 U/ml IL-4 
under these conditions. Bars represent means and standard deviations of 
triplicate determinations.  Results were comparable  in 10 mice. 
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Figure  2.  Progression  of L.  major infec- 
tion in i32m -/-  mice. (A) The designated 
mice were inoculated  in the hind footpads 
with L.  major promastigotes  and the size of 
the footpad lesion quantitated  over time us- 
ing a metric caliper. Symbols represent aver- 
age sizes of the footpads with standard  de- 
viations.  The  depicted  experiment  was 
representative  of 10  experiments  involving 
34  132m +  (both  +/+  and  +/-)  and  23 
[~2m  -/-  BALB/c  and  18  resistant 
C57BL/6  mice.  (B)  The  designated  mice 
were inoculated  in the hind footpads  with 
L.  major promastigotes  with  indicated  ani- 
mals also receiving neutralizing  IL-4 mAb 
(IxlL-4). Symbols represent  average sizes of 
the footpads with standard  deviations.  The 
depicted  experiment  was  representative  of 
three experiments. 
vitro in the presence or absence  of KLH  (Fig.  1).  Although 
variation  occurred  among  animals,  no  significant  differ- 
ences  in  IL-4 production  could  be  demonstrated  between 
the  two  cohorts  of  mice.  Similar  results  were  obtained 
comparing  C57BL/6  ~2m  +/-  to  C57BL/6  ~2m  -/- 
littermates  (data not shown). 
Evaluation  of Th2 Immune Responses in BALB/c mice Infect- 
ed with L.  major.  Although  infection  with  the  intramac- 
rophage  protozoan,  L.  major, induces strong Thl  responses 
in most strains of inbred mice, BALB/c mice develop aber- 
rant  Th2  responses  to  infection  that  underlie  the  suscepti- 
bility of this mouse strain  (43).  To assess whether this unusual 
"polymorphism"  in  Th2  development  (7)  was  dependent 
on  NT  cells, BALB/c  and  [~2m  -/-  BALB/c  mice were 
infected in the hind footpads with infectious promastigotes 
and the size of the lesions monitored using a metric caliper. 
Resistant  C57  background  mice  (C57BL/6  or  B10.D2) 
were  infected  for  comparative  purposes.  As  assessed  both 
by the size of the footpad  lesions  over time  (Fig.  2  A)  and 
direct  quantitation  of parasite  burdens  (data  not  shown), 
the  absence  of the  [32m  molecule  had  no  effect  on  the 
course  of the  infection  in  susceptible  BALB/c  mice.  Fur- 
ther, progressive disease in the ~2m  -/-  mice was depen- 
dent  on  early  production  of IL-4  in  vivo,  since  adminis- 
tration  of  neutralizing  antibody  to  IL-4  at  the  time  of 
infection allowed these mice to heal in a manner compara- 
ble to wild-type BALB/c  mice (Fig. 2  B). 
When  isolated lymph node  cells from the infected mice 
were incubated in vitro with L.  major antigens,  T  cells from 
~2m-deficient and wild-type BALB/c mice produced compa- 
rable  amounts  of IL-4  in  the  supernatants  that  was  signifi- 
cantly  greater  than  that  produced  by  concomitantly  stim- 
ulated  cells  from  infected  B10.D2  mice  (Fig.  3).  IL-4 
production  was  MHC  class  II  dependent,  consistent  with 
the  presence  of Th2  cells,  since  inclusion  of mAb  against 
class  II  abrogated  cytokine  production.  Direct  analysis  of 
lymph  node  IL-4  transcripts  using  competitive  P,T-PCR 
corroborated the restimulation assays:  infected BALB/c and 
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Production  of IL-4 by LN cells from mice infected with L.  Figure  3. 
major. LN cells draining the infection site were collected from the desig- 
nated mice and incubated for 48 b with media (open  bar), or with 100 btg/ml 
L.  major antigens without (closed bar) or with (stippled bar) anti-IA a mAb. 
Supematants  were collected and assayed for IL-4 by ELISA. Bars repre- 
sent mean and standard deviations of triplicate determinations.  Compara- 
ble results were obtained  in six experiments involving 13 aminals, includ- 
ing both +/-  and -/-  132m littermates. 
Figure  4.  Analysis of LN  cell 
IL-4  mP,  NA  transcript  levels  in 
mice infected  with  L.  major. LN 
draining the infected site were col- 
lected from the designated  mice 6 
wk  after  infection  with  L.  major 
and the total RNA used to prepare 
eDNA  by  reverse  transcription. 
Input  cDNAs were adjusted  until 
comparable  PCP,-mediated  anapli- 
fication  of the  constitutively  ex- 
pressed HPR.T gene was achieved 
as assessed by competition from an exogenous  competitor construct  that 
contains a larger PCR product that can be resolved as the upper band af- 
ter gel electrophoresis  from the more rapidly moving wild-type,  lower 
band.  Adjusted  cDNAs were used as templates for amplification  in  the 
presence  of the  same  competitor  that  also contains  IL-4  and  IFN-'y 
pseudogenes.  The  ratio  of the wild-type  (Iou,er) to  competitor  (upper) 
amplification  products  allows a semiquantitative  analysis of the relative 
anaounts ofcytokine transcripts in lymph node cells. P, esults were com- 
parable in five experiments. 
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Figure 5.  lgE levels in n'fice infected with L. major. Mice in the desig- 
nated groups had serum prepared 6 wk after infection with L. major. Total 
lgE was quantitated using ELISA. Results represent means and standard 
deviations of triplicate determinations from individual littermates either 
BALB/c +/-  (132m +) or -/-  132m. Comparable results  were obtained 
from four infected animals in each group. 
132m  +/-  or 132m  -/-  littermate BALB/c mice had sub- 
stantially greater  amounts  of IL-4  mRNA  than  infected 
C57BL/6 mice (Fig. 4). Finally, serum IgE levels were also 
comparably elevated in  infected BALB/c  [32m  +/-  and 
~2m  -/-  littermates  (Fig.  5),  consistent with  enhanced 
levels of IL-4 in vivo during the course of infection. 
Evaluation of Schistosoma  Egg-mediated  Pulmonary Granulo- 
mas.  Intravenous injection of eggs ofS. mansoni into mice 
presensitized with egg antigens induces prominent granulo- 
matous infiltration around the embolized eggs in the lungs 
that is associated with strong Th2  immune  responses (35). 
These  responses include induction  of multiple type 2  cy- 
tokines and predominant eosinophilic infiltrates. To exam- 
ine the role  of NT  cells in this type 2  granulomatous re- 
sponse, C57BL/6  and 132m  -/-  C57BL/6  mice that had 
been  presensitized to  egg  antigens  were  injected  intrave- 
nously  with  5,000  eggs  and  the  pulmonary  response  as- 
sessed histologically and by evaluation of the immune  re- 
sponse. 
At 6  and 10 d  after intravenous injection of eggs, granu- 
loma volumes did not differ between C57BL/6  wild-type 
and 132m  -/-  mice (Fig. 6 A). Histologic examination of 
the tissues revealed no  significant differences in the  num- 
bers of eosinophils in the granulomas  (Fig. 6  B).  To  assess 
the immune response, lung tissue was used to isolate RNA 
for quantitation of Th2  cytokines by reverse transcription- 
PCR.  As measured by fold increases from baseline (unin- 
jected)  lung  values  and  standardized to  the  constitutively 
expressed gene,  HPRT,  no  diminution in  the pulmonary 
Th2  response  was  evident  in  these  two  cohorts  of mice 
(Fig. 7). 
Evaluation of Intestinal Immunity against Nematodes.  When  in- 
jected subcutaneously larvae ofN.  brasiliensis migrate to the 
bloodstream and thence escape into the pulmonary alveo- 
lae. They are subsequently coughed up and swallowed, and 
thus  gain access to  the  small intestine where  they mature 
into  the  egg-laying adults.  Immunocompetent  mice  ex- 
pulse the adult worms shortly after the onset of egg laying, 
and expulsion is usually complete by 10-12 d. Depletion of 
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Figure 6.  The granulomatous response to eggs of S. mansoni in ~2m 
-/-  mice. (A) Four C57BL/6 or C57BL/6 132m -/-  mice were killed 
6 or 10 d after embolization of 5,000 eggs intravenously and the volume 
of the pulmonary granulomas was assessed  microscopically  on stained sec- 
tions. Results represent means and standard errors from the pooled results 
of four mice in each group. (B) The percentage of eosinophils in granu- 
loma cells surrounding single eggs was calculated using the histologic ma- 
terials examined in A. Results represent means and standard errors of the 
means. 
CD4 +  T  cells significantly delays expulsion  (40),  and  ad- 
ministration of IL-4 to  infected SCID  mice  enables these 
mice  to  expulse  the  worms  (44).  Infection  is  associated 
with dominant type 2  cytokine responses in the lungs and 
intestinal lymphoid tissues. To assess the role of NT cells in 
the  IL-4  response  induced  by  Nippostrongylus,  C57BL/6 
wild-type or  ~2m  -/-  mice  were  inoculated with  500 
third-stage larvae  and  examined  for  worm  expulsion  and 
the type of immune response produced. 
When  examined  12  d  after infection,  neither wild-type 
nor  [~2m  -/-  mice had any adult worms in the small or 
large intestines. Single-cell suspensions of isolated lung cells 
were used in ELISPOT assays to quantitate the numbers of 
IL-4-producing cells that had been produced during the nil- 
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Figure 7.  Th2 cytokine  responses in the lungs of mice challenged with 
eggs of S.  mattso;6. Lung homogenates  were used to prepare  cDNA for 
quantitative analysis of amounts of IL-4, I  L-5, and IL-13 transcripts as ex- 
pressed as fold increases as compared  with uninjected  control animals that 
are Oven an arbitrary value of 1. Results represent means and standard er- 
rors of the means from the lungs of four individual mice in each group. 
gration of the organisms.  No significant effect on IL-4-pro- 
ducing  cells  could  be  discerned  by  the  absence  of [32m 
(Fig.  8  At.  Further,  there were no significant differences in 
blood  eosinophilia  (wild-type:  13.3  +/-  4%  versus  [32m 
-/-:  13.2  +/-  5%, as compared to  1.3% and  1.7% in un- 
infected  control  mice  of the  respective genotypes)  nor  se- 
rum  IgE  levels  (Fig.  8  /3)  in  the  two  groups  of infected 
mice. 
Evaluation1  olAiru,ay  Mucosal Immune  Responses.  Airway 
hyperreactivity  can  be  established  in  BALB/c  mice  by 
aerosolizing  antigen  to  animals  previously  sensitized  by 
subcutaneous  immunization  with  the  same  antigen.  Using 
OVA,  hyperreactivity  as  assessed  by  increases  in  airway 
pressure  and  resistance  after  injection  of Ach  was  demon- 
strated  to be dependent  on the presence  of IL-4 during the 
initial period  of immunization  with  OVA  (38).  Neutraliz- 
Figure 8.  Type 2 inmmne responses in mice infected with  N.  brasilictl- 
sis. (At  Wild-type C57BL/6 or [32m -/-  C57BL/6 mice  were either 
uninfected  or challenged with  larvae of N.  l~msilie~tsis. After  t2 d, single- 
cell suspensions of the whole hmg were analyzed fi>r numbers  of IL-4- 
producing  cells using the EL[SPOT assay. Bars represent  means and stan- 
dard deviations from  duplicate  determinations  from five animals, t~,esults 
are representative  of two experiments.  (B) Wild-type C57BL/6 or [~2m 
-/-  C57BL/6 were either left uninfected  or infected  with larvae of N. 
hrasiliet;sis. After 12 d, serum was prepared  and analyzed for total IgE by 
ELISA. Results represent  means and standard deviations of duplicate  de- 
terminations  from five mice in each group.  Results are representative  of 
two experinlents. 
ing antibody to IL-4 given during the subcutaneous  sensiti- 
zation  period abrogated  the  subsequent  airway  response  to 
inhaled OVA,  as well as the type 2  cytokine profile in lung 
cells,  but  had  little  effect on  pulmonary  eosinophilia.  To 
assess the role of NT  cells in this airway model of Th2  sen- 
sitization,  BALB/c  or  ~2m  -/-  BALB/c  mice  were  im- 
munized  subcutaneously  with  OVA  and  airway  hyper- 
reactivity and  immune  responses  quantitated  after multiple 
aerosol exposures  to OVA. 
As assessed  using incremental  increases  in  Ach  to  deter- 
mine  the  concentration  required  to  increase  R,t.  by  200%, 
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Figure  9.  Induction of airway hyperreactivity by aerosolization  of antigen to sensitized  mice.  (A) Wild-type BALB/c or ]32m -/-  BALB/c mice 
were presensitized  with OVA before aerosolization  of saline (control) or OVA. After 24 h, animals were anesthetized  and placed  on rodent ventilators  in- 
side a plethysmograph. Incrementally increasing doses of Ach were administered intravenously and the provocative dose that caused  a 200% increase  in 
lung resistance  was calculated.  Bars represent means and standard  errors of the means from four individual  mice in each group. Results are representative 
of two experiments. (B) Single-cell  suspensions from the animals from the groups analyzed  in A were prepared and assayed for numbers of IL-4-produc- 
ing cells in an ELISPOT assay. Bars represent means and standard  errors of the means from four mice in each group. (C) Serum from the animals from the 
groups analyzed  in A was prepared and assayed for total IgE by ELISA. Bars represent means and standard  errors of the means of duplicate  determinations 
from four mice in each group. 
no significant differences in either lung resistance (Fig.  9 A) 
or airway pressure (data not shown) were apparent between 
[32m  -/-  mice  and  wild-type  controls.  The  pulmonary 
immune response was determined by evaluation of individ- 
ual  IL-4-producing  cells  by  ELISPOT  assay  of isolated 
whole lung cells  (Fig.  9/3)  and the serologic response was 
assayed by quantitating total serum [gE (Fig.  9  C). Neither 
of these assays demonstrated diminished responses in mice 
without ]32m. 
Discussion 
A  number of characteristics suggest that NT cells might 
be the source of early IL-4 required for commitment of na- 
ive CD4 + T  cells to the Th2 phenotype during an immune 
response.  First,  cross-linking the antigen  receptors on NT 
cells, in contrast to naive cl/[3 + T  cells, results in rapid pro- 
duction of large amounts of IL-4, the critical cytokine re- 
quired  for Th2  differentiation  (27,  33).  Second,  NT cells 
display a restricted TCR  repertoire  that is selected by the 
nonpolymorphic  MHC  class  I  molecule,  CD1  (28-31). 
Such structural constraints would be consistent with recog- 
nition  shaped by conserved microbial ligands from patho- 
genic organisms. Indeed, CD4-CD8-  human T  cells have 
been isolated that recognize mycolic acids and lipoglycans 
from mycobacteria in  the  context  of CDlb  (45,  46).  M- 
though mice express only one of the five human CD1  ho- 
mologues,  presumably  due  to  an  ancient  translocation 
event that split chromosome  1  (47),  the locus  has already 
been  duplicated  to  form two  closely related genes,  desig- 
nated  CDI.1  and  CD1.2,  consistent  with  evolutionary 
pressure to maintain expression of these molecules.  Third, 
mice  deficient  in  NT  cells,  either  through  disruption  of 
[32m necessary for efficient surface expression of CD 1 (29- 
31)  or genetically, as in SJL mice, do not mount typical IL-4 
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responses  and  IgE  elevations in  response  to  anti-CD3  or 
anti-IgD antibodies in vivo (33, 48). The common require- 
ment  for  IL-4 production  in  vivo in  response  to  diverse 
type 2-inducing agents would be consistent with an invari- 
ant population poised to recognize microbial agents and re- 
lease  IL-4 in  sufficient amounts to direct Th2  differentia- 
tion of naive T  cells. 
With  these  considerations, we examined Th2 responses 
in  [32m-deficient  mice  on  both  BALB/c  and  C57BL/6 
backgrounds  using  a  variety of challenges  that  are  docu- 
mented  to  induce  dominant  Th2  immune  responses  in 
vivo. Neutralization  of IL-4 at the  time of inoculation  of 
KLH (42),  L.  major (49),  eggs ofS.  mansoni (50,  5l), larvae 
of N. brasiliensis (52),  and subcutaneous immunization with 
OVA in airway hyperreactivity (38)  has consistently abro- 
gated most type 2 responses, including production of type 
2 cytokines and elevation of serum IgE. Similarly, neutral- 
ization oflL-4 at the time of administration ofanti-CD3 or 
anti-IgD profoundly impairs type 2 immune responses (52), 
and this effect is presumably due to blocking the differenti- 
ation of naive T  cells,  since the production of 1L-4 by NT 
cells  is  unaffected  by neutralization  of IL-4  (33).  Despite 
the comparable effects of anti-IL-4 in these systems, how- 
ever, we  could  discern  no  significant impairment of Th2 
responses in the absence of [32m. 
The  systems investigated  represented  a  variety of anti- 
gens administered by different routes to animals on two ge- 
netic backgrounds that have been shown to differ in their 
capacity to generate type 2 responses to some antigens (7). 
We have also  measured responses at two mucosal surfaces 
(airway hyperreactivity, intestinal worm expulsion), in var- 
ious  tissues  (subcutaneous  leishmania  lesions,  schistosoma 
egg pulmonary granulomas), and in draining lymph nodes 
(KLH, leishmania responses). Using a variety of functional 
and  immunologic  assays,  we  could  discern  no  substantial differences  in  the  responses  between  wild-type,  heterozy- 
gous littermates  or [32m-null mice. Recent studies investi- 
gating  L.  major  infection  (53)  and  responses  to  low-dose 
antigen (54) in BALB/c mice were also unable to incrimi- 
nate a role for NT cells in type 2 immune responses. These 
data suggest that most biologic Th2 responses are [32m in- 
dependent,  and thus distinct from the type 2 response gen- 
erated after anti-CD3 or anti-IgD. 
Several possibilities should be considered before dismiss- 
ing a  potential  role  for NT  cells  in Th2  responses,  how- 
ever, Although both flow cytometric and functional studies 
suggest that the NT population is absent in [32m-null mice 
(29-33),  it  is  possible  that  a  residual  population  of CD1- 
restricted T  cells  remains.  A  number of hybridomas gener- 
ated  from the  small  numbers  of CD4 +  T  cells  present  in 
class II  ~ and class II~  ~ mice were reactive to CD1  and 
shared the mature/activated  phenotype typically found on 
NT cells  (55). Expression of transfected CDI.1  and its  hu- 
man homologue, CDld,  has been achieved in the absence 
of [32m (56).  It is possible that a small residual NT popula- 
tion in 132m-null mice is capable of generating IL-4 under 
the conditions of most type 2 immune responses, but is in- 
capable  of responding to rapid activation  after administra- 
tion  of anti-CD3  or  anti-IgD  antibodies.  An  alternative 
strategy  to  eliminate  NT  cells  using  mAb  depletion  of 
NK1.1-bearing cells from BALB/c mice congenic for NK1.1 
expression  also  failed  to  ameliorate  susceptibility  (Brown, 
D.R.,  and  S.L.  Reiner,  unpublished  results).  It  is  likely, 
however,  that  mice  with  disruption  of the  CDI.1  and 
CDI.2  genes will  need to be infected with  these  types of 
pathogens to exclude definitively a role for NT cells in Th2 
development. 
An  alternative  possibility  is  that  these  diverse  biologic 
Th2 responses activate distinct populations of cells as com- 
pared  with  anti-CD3  or anti-IgD.  Cells  of the  mast  cell/ 
basophil lineage have been implicated  in maintaining IL-4 
production after S.  mansoni (57)  and N.  brasiliensis (58)  in- 
fections, and eosinophils have been implicated in the early 
production of IL-4 after intraperitoneal injection of S. man- 
soni eggs (59).  Intraperitoneal injection of N.  brasiliensis in- 
duced early IL-4 production from y8 + T  cells  (60).  In L. 
major infection, mast cell-deficient mice developed smaller 
lesions  that  were  augmented  after  passive  transfer  of mast 
cells  into  the  lesion  site  (61).  Despite  these  observations, 
the most convincing data in each of these systems implicate 
CD4 + T  cells  as the major source of IL-4 in directing Th 
differentiation. An unusual subpopulation of class II-restricted 
T  cells  or a propensity for certain antigens to activate naive 
CD4 +  T  cells  to favor IL-4-mediated responses  over IL- 
12/IFN-~/-mediated responses remain untested but plausi- 
ble hypotheses. 
Although use of ~2m-deficient mice remains imperfect, 
the available data suggest that these animals are incapable of 
supporting the differentiation of NT cells  in vivo. As dem- 
onstrated  here,  these  mice  support  Th2  development  in 
vivo in a manner indistinguishable  from wild-type mice in 
response  to  a  wide  variety  of immunologic  challenges. 
Such systems should prove invaluable for further studies at- 
tempting to identify the critical early source of IL-4 impli- 
cated  in  Th2  effector  cell  differentiation  and  activation. 
Elucidation of the source oflL-4 remains an important goal 
for understanding  and modulating the development of the 
immune response,  particularly in allergic  disorders  and in- 
testinal host defense. 
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